Materias dentro de su búsqueda.
Materias dentro de su búsqueda.
-
3381por Zeng, Chuan, Xiong, Weijun, Li, Xiang, Reyngold, Marsha, Gewanter, Richard M., Cuaron, John J., Yorke, Ellen D., Li, Tianfang“…In this study, we used the intrafraction motion review (IMR) application to directly track an internal target and characterized the residual motion during DIBH treatment for pancreatic cancer patients through their full treatment courses. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3382por Bazzichetto, Chiara, Conciatori, Fabiana, Falcone, Italia, Cognetti, Francesco, Milella, Michele, Ciuffreda, Ludovica“…The goal of this review is to give an overview of the most relevant cytokines involved in colorectal and pancreatic cancer progression and their implication in drug response.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3383por Hu, Qiangsheng, Qin, Yi, Xiang, Jinfeng, Liu, Wensheng, Xu, Wenyan, Sun, Qiqing, Ji, Shunrong, Liu, Jiang, Zhang, Zheng, Ni, Quanxing, Xu, Jin, Yu, Xianjun, Zhang, Bo“…OBJECTIVES: Decreased deoxycytidine kinase (dCK) expression is a reported indicator of gemcitabine efficacy in pancreatic cancer, due to the impact of this kinase on gemcitabine metabolism. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3384
-
3385
-
3386“…Pancreatic cancer (PC) has posed a great health threat to a growing number of people all over the world. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3387por van Mackelenbergh, Madelaine G., Stroes, Charlotte I., Spijker, René, van Eijck, Casper H.J., Wilmink, Johanna W., Bijlsma, Maarten F., van Laarhoven, Hanneke W.M.“…The PEGPH20 clinical trials used patient selection to determine eligibility based on tumor biology, which underlines the importance to personalize treatment for pancreatic cancer patients.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3388por Tataranni, Tiziana, Agriesti, Francesca, Pacelli, Consiglia, Ruggieri, Vitalba, Laurenzana, Ilaria, Mazzoccoli, Carmela, Della Sala, Gerardo, Panebianco, Concetta, Pazienza, Valerio, Capitanio, Nazzareno, Piccoli, Claudia“…In this study, we investigated the response of two pancreatic cancer cell lines to DCA, in two-dimensional and three-dimension cell cultures, as well as in a mouse model. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3389
-
3390por Goehrig, Delphine, Nigri, Jérémy, Samain, Rémi, Wu, Zhichong, Cappello, Paola, Gabiane, Gaëlle, Zhang, Xinyi, Zhao, Yajie, Kim, In-San, Chanal, Marie, Curto, Roberta, Hervieu, Valerie, de La Fouchardière, Christelle, Novelli, Francesco, Milani, Pascale, Tomasini, Richard, Bousquet, Corinne, Bertolino, Philippe, Hennino, Ana“…OBJECTIVE: Pancreatic cancer is associated with an abundant stromal reaction leading to immune escape and tumour growth. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3391
-
3392“…The main purposes of this study were to examine the expression of CD137 in pancreatic cancer cells and to investigate its underlying mechanisms. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3393por Wang, Man-Tzu, Fer, Nicole, Galeas, Jacqueline, Collisson, Eric A., Kim, Sung Eun, Sharib, Jeremy, McCormick, Frank“…Our data suggest a crucial role of LIF in KRAS-driven pancreatic cancer and that blockade of LIF by neutralizing antibodies represents an attractive approach to improving therapeutic outcomes.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3394por Zhao, Jiangang, Schlößer, Hans A., Wang, Zhefang, Qin, Jie, Li, Jiahui, Popp, Felix, Popp, Marie Christine, Alakus, Hakan, Chon, Seung-Hun, Hansen, Hinrich P., Neiss, Wolfram F., Jauch, Karl-Walter, Bruns, Christiane J., Zhao, Yue“…We isolated EVs from a highly-metastatic pancreatic cancer cell line and patient-derived primary cancer cells by ultracentrifugation. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3395
-
3396por Moreau, Michele, Ibeh, Udoka, Decosmo, Kaylie, Bih, Noella, Yasmin-Karim, Sayeda, Toyang, Ngeh, Lowe, Henry, Ngwa, Wilfred“…Pancreatic cancer is particularly refractory to modern therapies, with a 5-year survival rate for patients at a dismal 8%. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3397por Sutaria, Dhruvitkumar S., Jiang, Jinmai, Azevedo-Pouly, Ana Clara, Wright, Lais, Bray, Julie A., Fredenburg, Kristianna, Liu, Xiuli, Lu, Jun, Torres, Carolina, Mancinelli, Georgina, Grippo, Paul J., Coppola, Vincenzo, Schmittgen, Thomas D.Enlace del recurso
Publicado 2019
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3398“…BACKGROUND: Pancreatic cancer is a deadly malignancy with aggressive properties. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3399por Adamska, Aleksandra, Domenichini, Alice, Capone, Emily, Damiani, Verena, Akkaya, Begum Gokcen, Linton, Kenneth J., Di Sebastiano, Pierluigi, Chen, Xi, Keeton, Adam B., Ramirez-Alcantara, Veronica, Maxuitenko, Yulia, Piazza, Gary A., De Laurenzi, Vincenzo, Sala, Gianluca, Falasca, Marco“…CONCLUSIONS: Our results indicate that ABCC3 inhibition with MCI-715 demonstrated strong antitumor activity and is well tolerated, which leads us to conclude that ABCC3 inhibition is a novel and promising therapeutic strategy for a considerable cohort of patients with pancreatic cancer. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13046-019-1308-7) contains supplementary material, which is available to authorized users.…”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
3400por Li, Yilong, Kong, Rui, Chen, Hongze, Zhao, Zhongjie, Li, Le, Li, Jiating, Hu, Jisheng, Zhang, Guangquan, Pan, Shangha, Wang, Yongwei, Wang, Gang, Chen, Hua, Sun, Bei“…Despite improvements in surgical procedures and comprehensive therapies, pancreatic cancer remains one of the most aggressive and deadly human malignancies. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto